Skip to content

AI Assisted Study of ultrasound scoring and grading system for ovarian tumors

AI Assisted Study of ultrasound scoring and grading system for ovarian tumors

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037358
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic tumor

Interventions

Gold Standard:Pathology
model&#32
based&#32
on&#32
ultrasound&#32
and&#32
system&#32
for&#32
tumors

Sponsors

Shanghai First Maternity and infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: From August 2018 to June 2022, 3000 patients with ovarian tumor in our hospital were randomly selected. All patients underwent transvaginal ultrasound examination. The patients were treated with surgery 24-72 hours after examination, and followed up with pathology after operation.

Exclusion criteria

Exclusion criteria: Patients who have undergone pelvic surgery or radiotherapy, chemotherapy or other treatments for pelvic malignancies.

Design outcomes

Primary

MeasureTime frame
Ultrasonic characteristics;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactRen Min

Shanghai First Maternity and infant Hospital

dochrm@163.com+86 18918323179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026